From Name:
From Email:
To Name:
To Email:

Optional Message:

Bisphosphonate therapy underutilized in multiple myeloma bone disease management

from Oncology Nurse Advisor

Patients with multiple myeloma may not be receiving optimal therapeutic management for bone disease, according to a study published in Supportive Care in Cancer. Current treatment recommendations suggest initiating intravenous bisphosphonates (eg, zoledronic acid, clodronate, pamidronate) for patients with multiple myeloma, not only for bone disease but also, as previous studies have demonstrated, possible benefit to overall survival and progression-free survival. The direction of treatment upon response to primary myeloma therapy and real-world use in this patient population, however, requires further investigation. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063